Prostate Cell News Volume 16.13 | Jul 18 2025

    0
    52







    2025-07-18 | PCN 16.13


    Prostate Cell News by STEMCELL Technologies
    Vol. 16.13 – 18 July, 2025
    TOP STORY

    A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy

    Glutamine depletion reduced forkhead box protein M1 transcriptional occupancy on the promoter of FGF8, a known mediator of prostate adenocarcinoma castration resistance.
    [Cancer Research]

    Abstract
    Graphical Abstract
    Learn how to avoid jargon and use blogs and social media channels to inform the public about your science
    PUBLICATIONSListed by the impact factor of the journal

    Proteomic Profiling of Urinary Large Extracellular Vesicles for the Diagnosis of Prostate Cancer

    Researchers created an urinary large extracellular vesicles-centric proteomic approach for early prostate cancer identification.
    [Analytical Chemistry]

    AbstractGraphical Abstract

    Androgen Receptors Expressed in the Primary Sensory Neurons Regulate Mechanical Pain Sensitivity

    Scientists investigated androgen receptor involvement in pain sensitivity and sex differences in pain perception. Manipulating androgen signaling in sensory neurons may offer a promising approach to managing mechanical pain.
    [Pain]

    Full Article

    Risk Factors for Low-Risk Prostate Cancer: A Retrospective Cohort Study within the FinRSPC Trial

    This retrospective cohort study of 80,144 men from the Finnish Randomized Study of Screening for Prostate Cancer (PC), with a median follow-up of 18.0 years, compared determinants of low-risk PC with determinants of high-risk PC.
    [International Journal of Cancer]

    Full Article

    Screening and Validation of Key Genes Involved in Castration-Resistant Prostate Cancer Based on Transcriptomics Sequencing

    Investigators suggested that S100A6 may serve as a molecular marker or therapeutic target associated with castration resistance in prostate cancer, providing new insights into the molecular basis of this disease.
    [Scientific Reports]

    Full Article

    Prognostic Value of LncRNA PSMA3-AS1 in Prostate Cancer and Its Potential Regulatory Mechanism

    PSMA3-AS1 knockdown increased the level of miR-29a-3p and reduced the physiological activity of cancer cells. Therefore, regulating the expression of the PSMA3-AS1/miR-29a-3p axis could influence prostate adenocarcinoma development.
    [Hereditas]

    Full Article
    Tumors Are 3D. Shouldn't Your In Vitro Model Be? Learn More.
    REVIEWS

    Copper Death Combination Therapy: The Innovative Frontier and Challenges in Prostate Cancer Treatment

    The authors synthesize current findings on the role of copper and cuproptosis in prostate cancer, focusing on the mechanisms underlying cuproptosis, the identification of key biomarkers, and the therapeutic potential of copper complexes and ionophores.
    [Cancer Biology & Therapy]

    Full Article

    Integration of Prostate-Specific Membrane Antigen-PET and Multiparametric MRI for Gross Tumor Volume Definition in Localized and Locally Advanced Prostate Cancer Treated with Image-Guided Radiotherapy

    Scientists evaluate recent evidence on the utility of multiparametric MRI, prostate-specific membrane antigen PET, and their combined application for accurately delineating the intraprostatic gross tumor volume in patients with primary localized and locally advanced prostate cancer.
    [Current Opinion in Urology]

    Full Article
    INDUSTRY AND POLICY NEWS

    FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer

    Trethera Corporation announced that the US FDA has granted Fast Track designation for its novel drug, TRE-515, in the treatment of prostate cancer.
    [Trethera Corporation]

    Press Release
    FEATURED EVENT

    9th Annual IPF Summit

    August 19-21, 2025
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Associate – National Prostate Cancer Bio-Digital Twin

    Imperial College London – London, England, United Kingdom

    PI Positions – Regenerative Biology and Medicine

    The Chinese Institutes for Medical Research (CIMR), Beijing – Beijing, China

    Scholarship – Prostate Cancer Research

    Monash University – Melbourne, Australia

    Assistant/Associate/Full Professor – Cancer Biology

    Indiana University – Bloomington, Indiana, United States

    MSc Student – Tissue Regeneration and Cancer

    University of Glasgow – Glasgow, Scotland, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2